Cite
MLA Citation
M. Forster et al.. “Phase I study of lurbinectedin (PM01183) in combination with cisplatin (CDDP) with or without aprepitant in patients (pts) with advanced solid tumors.” European journal of cancer, vol. 72, n.d., pp. S134–. http://access.bl.uk/ark:/81055/vdc_100041522256.0x000047